AstraZeneca’s Lokelma Approved In US With Label Benefits Over Veltassa

 
• By Lucie Ellis-Taitt
Dollar sign
Analysts ponder whether late-to-market Lokelma can still reach blockbuster status • Source: Shutterstock

More from New Products

More from Scrip